Our Blog

Nominated For HealthInvestor Awards

Re:Cognition Health Shortlisted For Two HealthInvestor Awards     We are absolutely delighted to announce that Re:Cognition Health has been shortlisted for two awards in the highly […]

How To Deal With Baby Brain?

Dr. MacSweeney offers advice on battling with Baby Brain Brain fog, otherwise affectionately known as “baby brain” or “mumnesia” can be experienced during and post pregnancy with […]

“Ask the Doctor” with Re:Cognition Health

Re:Cognition Health Launches Facebook Live “Ask the Doctor” Events   Re:Cognition Health is delighted to announce the launch of our “Ask the Doctor” series on Facebook Live […]

Dr. Emer MacSweeney to Speak at Naidex

Dr. Emer MacSweeney Confirmed as Speaker at Naidex Exhibition 17th & 18th March, NEC, Birmingham   We are delighted to announce that Dr Emer MacSweeney, Founder, CEO […]

How Do You Keep Your Brain Healthy?

Top Tips for Keeping Your Brain Healthy and Strong Our team of Brain and Mind experts are dedicated to paving a way for a future without dementia. […]

Addiction

Addiction may be more wide-spread than you think – according to Action on Charity one in three people is addicted to something. We commonly think of alcohol […]

Re:Cognition Health Wins Award

Re:Cognition Health Honoured for Positive Impact in Growing Business Awards   We are absolutely delighted to announce that Re:Cognition Health won The Bridges Positive Impact award at […]

Obsessive Compulsive Disorder

OBSESSIVE COMPULSIVE DISORDER A serious mental health concern   Dr Dimitrios Paschos, Consultant Psychiatrist at Re:Cognition Health was interviewed by Yahoo! News about Obsessive Compulsive Disorder (OCD). […]

New Migraine Treatment Approved

Migraine Treatment Receives FDA Approval in the USA Drug currently undergoing UK clinical trial at Re:Cognition Health REYVOW (lasmiditan) is a migraine medication which is currently undergoing […]

First treatment to slow Alzheimer’s progression

Re:Cognition Health proud to be part of ground-breaking clinical trial   Dr Emer MacSweeney, CEO at Re:Cognition Health shares her excitement about the potential success of Aducanumab, […]